Lilly needs a plan to spur weight-loss drug sales, investors say
Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...
RFK Jr. Is Right: Kids Don’t Need Weight-Loss Drugs
Too many young people are prescribed pills for mental illness. Are we repeating history with GLP-1s?
As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs
Novo Nordisk's Karsten Munk Knudsen is targeting 800 million obese people globally.
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street's concerns with its fourth-quarter results and 2025 outlook.
Prescriptions for weight loss drugs are skyrocketing, especially among young women. Experts think they know why.
The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...
Whoopi Goldberg Warns Against AI-Created Ad Using Her Image to Sell Weight-Loss Drug: ‘Do Not Fall for It!’
The EGOT winner railed against an ad that's circulating on social media with a manipulated version of her promoting "bad ...
Weight loss pill could replace injections, would be transformative for millions
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
Sharon Osbourne emerges for the first time in months as she announces Black Sabbath reunion - after admitting she still suffers Ozempic side-effects despite quitt…
Sharon was on hand to promote the event alongside the band's originals guitarist Tony Iommi, after admitting she is ...
Novo Nordisk defends next-gen obesity drug CagriSema, gives details of new trial
Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...
Novo Nordisk beats on Wegovy sales, expects slower 2025 growth
Novo's earnings results Wednesday differ from Eli Lilly's, whose stock slid on slower-than-expected sales of weight loss ...
Novo Nordisk: Among The Best Opportunities Of The Moment (Rating Upgrade)
Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.
Ram Kapoor flexes big arms, proves drastic 55 kg weight loss is not from Ozempic or surgery. Watch video
In a new video, Ram Kapoor proved that his 55 kg weight loss transformation was not because of ozempic or surgery. Instead, he achieved it through hard work.